ATRA vs RUN · rev $128.9M vs P/E 6.0, rev $2.04B
Atara Biotherapeutics Inc (ATRA) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
ATRA currently screens at market cap $87.1M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the ATRA and RUN stock pages for the full models.
Not investment advice.